← MICRON TECHNOLOGY INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $12.4b |
$20.3b
+63.90%
|
$30.4b
+49.55%
|
$23.4b
-22.98%
|
$21.4b
-8.42%
|
$27.7b
+29.25%
|
$30.8b
+11.02%
|
$15.5b
-49.48%
|
$25.1b
+61.59%
|
$37.4b
+48.85%
|
$90.3b
+141.52%
|
|
| Cost of Revenue | $9.9b |
$11.9b
+20.13%
|
$12.5b
+5.17%
|
$12.7b
+1.63%
|
$14.9b
+17.15%
|
$17.3b
+16.12%
|
$16.9b
-2.44%
|
$17.0b
+0.57%
|
$19.5b
+14.99%
|
$22.5b
+15.42%
|
$24.8b
+10.03%
|
|
| Cost of goods sold | $9.9b |
$11.9b
+20.13%
|
$12.5b
+5.17%
|
$12.7b
+1.63%
|
$14.9b
+17.15%
|
$17.3b
+16.12%
|
$16.9b
-2.44%
|
$17.0b
+0.57%
|
$19.5b
+14.99%
|
$22.5b
+15.42%
|
$24.8b
+10.03%
|
|
| Gross margin | $2.5b |
$8.4b
+236.77%
|
$17.9b
+112.08%
|
$10.7b
-40.18%
|
$6.6b
-38.78%
|
$10.4b
+59.08%
|
$13.9b
+33.34%
|
($1.4b)
-110.19%
|
$5.6b
+496.40%
|
$14.9b
+164.97%
|
$65.5b
+340.47%
|
|
| Gross Profit | $2.5b |
$8.4b
+236.77%
|
$17.9b
+112.08%
|
$10.7b
-40.18%
|
$6.6b
-38.78%
|
$10.4b
+59.08%
|
$13.9b
+33.34%
|
($1.4b)
-110.19%
|
$5.6b
+496.40%
|
$14.9b
+164.97%
|
$65.5b
+340.47%
|
|
| Research and Development Expense | $1.6b | $1.8b | $2.1b | $2.4b | $2.6b | $2.7b | $3.1b | $3.1b | $3.4b | $3.8b | $4.8b | |
| Selling, General and Administrative Expense | $659.0m | $743.0m | $813.0m | $836.0m | $881.0m | $894.0m | $1.1b | $920.0m | $1.1b | $1.2b | $1.4b | |
| Amortization of Intangible Assets | $117.0m | $106.0m | — | — | — | $82.0m | $85.0m | $86.0m | $82.0m | $71.0m | — | |
| Restructuring and Related Cost, Incurred Cost | — | — | — | — | — | — | — | $171.0m | — | — | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | $168.0m |
$5.9b
+3392.86%
|
$15.0b
+155.52%
|
$7.4b
-50.81%
|
$3.0b
-59.29%
|
$6.3b
+109.22%
|
$9.7b
+54.42%
|
($5.7b)
-159.21%
|
$1.3b
+122.70%
|
$9.8b
+649.23%
|
$59.3b
+506.78%
|
|
| Other Operating Income (Expense), Net | $6.0m | $17.0m | $57.0m | ($49.0m) | ($68.0m) | ($95.0m) | $34.0m | ($124.0m) | $251.0m | ($61.0m) | — | |
| Interest Expense | $437.0m | $601.0m | $342.0m | $128.0m | $194.0m | $183.0m | $189.0m | $388.0m | $562.0m | $477.0m | $230.0m | |
| Interest income | $42.0m | $41.0m | $120.0m | $205.0m | $114.0m | $37.0m | $96.0m | $468.0m | $529.0m | $496.0m | $655.0m | |
| Investment Income, Net | $42.0m | $41.0m | $120.0m | $205.0m | $114.0m | $37.0m | $96.0m | $468.0m | $529.0m | $496.0m | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($24.0m) | ($74.0m) | ($75.0m) | ($9.0m) | ($8.0m) | — | — | — | — | ($72.0m) | — | |
| Gain (Loss) Related to Litigation Settlement | $0 | — | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Investments | — | — | — | — | — | $82.0m | $26.0m | ($8.0m) | — | — | — | |
| Equity in net income (loss) of equity method investees | $25.0m | $8.0m | ($1.0m) | $3.0m | $7.0m | $37.0m | $4.0m | $2.0m | ($11.0m) | $9.0m | — | |
| Income (Loss) from Equity Method Investments | $25.0m | $8.0m | ($1.0m) | $3.0m | $7.0m | $37.0m | $4.0m | $2.0m | ($11.0m) | $9.0m | — | |
| Income (loss) before income taxes and equity in net income (loss) of equity method investees | ($281.0m) | $5.2b | $14.3b | $7.0b | $3.0b | $6.2b | $9.6b | ($5.7b) | $1.2b | $9.7b | — | |
| Other Nonoperating Income (Expense) | ($54.0m) | ($112.0m) | ($465.0m) | ($405.0m) | $60.0m | $81.0m | ($38.0m) | $7.0m | ($31.0m) | ($135.0m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $72.0m | ($56.0m) | $141.0m | ($67.0m) | $308.0m | ($211.0m) | $112.0m | $235.0m | $544.0m | $686.0m | $59.1b | |
| Current Income Tax Expense (Benefit) | $28.0m | $153.0m | $427.0m | $357.0m | $170.0m | $413.0m | $594.0m | $184.0m | $416.0m | $960.0m | $8.6b | |
| Income tax (provision) benefit | ($19.0m) | ($114.0m) | ($168.0m) | ($693.0m) | ($280.0m) | ($394.0m) | ($888.0m) | ($177.0m) | ($451.0m) | ($1.1b) | — | |
| Net Income (Loss) Attributable to Parent | ($276.0m) |
$5.1b
+1943.84%
|
$14.1b
+177.76%
|
$6.3b
-55.34%
|
$2.7b
-57.44%
|
$5.9b
+118.12%
|
$8.7b
+48.22%
|
($5.8b)
-167.15%
|
$778.0m
+113.34%
|
$8.5b
+997.56%
|
$50.5b
+491.04%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.0m | $1.0m | $3.0m | $45.0m | $23.0m | $0 | $0 | — | — | — | $50.5b | |
| Earnings Per Share, Basic | ($0.27) | $4.67 | $12.27 | $5.67 | $2.42 | $5.23 | $7.81 | ($5.34) | $0.70 | $7.65 | $44.83 | |
| Earnings Per Share, Diluted | ($0.27) | $4.41 | $11.51 | $5.51 | $2.37 | $5.14 | $7.75 | ($5.34) | $0.70 | $7.59 | $44.24 | |
| Common Stock, Dividends, Per Share, Declared | $0.27 | $4.67 | $12.27 | $5.67 | $2.42 | $5.23 | $0.32 | $0.46 | $0.46 | $0.46 | — | |
| Basic (in shares) | $1.0b | $1.1b | $1.2b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | |
| Diluted (in shares) | $1.0b | $1.2b | $1.2b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | $1.1b | |
| Weighted Average Number of Shares Outstanding, Basic | 1.0b | 1.1b | 1.2b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | |
| Weighted Average Number of Shares Outstanding, Diluted | 1.0b | 1.2b | 1.2b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | 1.1b | |
| Additional Financial Items | ||||||||||||
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | $7.0m | $32.0m | $10.0m | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | — | $101.0m | $0 | $0 | $0 | |
| Litigation Settlement Loss | — | — | — | — | — | — | — | — | $0 | $0 | — | |
| Restructure and asset impairments | $67.0m | $18.0m | — | ($29.0m) | $60.0m | $488.0m | $48.0m | $171.0m | $1.0m | $39.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.